Publication & Citation Trends
Publications
0 total
Phase II Study of Dovitinib in Patients Progressing on Anti-Vascular Endothelial Growth Factor Therapy. OA
Cited by 24
Semantic Scholar
Phase II study of dovitinib in patients (Pts) progressing on anti-vascular endothelial growth factor (VEGF) therapy.
Cited by 5
Semantic Scholar
Pharmacodynamic separation of gemcitabine and erlotinib in locally advanced or metastatic pancreatic cancer: therapeutic and biomarker results OA
Cited by 28
Semantic Scholar
Pharmacodynamic separation (PDS) of gemcitabine (Gem) and the epidermal growth factor receptor (EGFR) inhibitor erlotinib (E) in patients (Pts) with advanced pancreatic cancer: Phase II results.
Cited by 0
Semantic Scholar
Escalating weekly doses of cetuximab and correlation with skin toxicity: A phase I study OA
Cited by 16
Semantic Scholar
A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer
Cited by 270
Semantic Scholar
Rash severity and dose in phase I dose escalation cetuximab (C225) trial
Cited by 3
Semantic Scholar
Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033.
Cited by 996
Semantic Scholar
Population-Based Phase I Trial of Irinotecan and Epirubicin
Cited by 2
Semantic Scholar
Research Topics
Lung Cancer Treatments and Mutations
(5)
Colorectal Cancer Treatments and Studies
(5)
Ethics in Clinical Research
(3)
Gastric Cancer Management and Outcomes
(3)
Health Systems, Economic Evaluations, Quality of Life
(3)
Affiliations
Pelita Harapan University
Micron (United States)
Tan Tock Seng Hospital
University of Illinois Chicago
Dr. Hasan Sadikin General Hospital